Last10K.com

America Great Health (AAGH) SEC Filing 10-K Annual report for the fiscal year ending Friday, June 30, 2017

America Great Health

HISTORY TOOLS
CIK: 1098009 Ticker: AAGH
Document And Entity Information - USD ($)
12 Months Ended
Jun. 30, 2017
Sep. 26, 2017
Dec. 31, 2016
Document and Entity Information [Abstract]   
Entity Registrant NameAmerica Great Health  
Document Type10-K  
Current Fiscal Year End Date--06-30  
Entity Common Stock, Shares Outstanding 20,236,021,800 
Entity Public Float  $ 0
Amendment Flagfalse  
Entity Central Index Key0001098009  
Entity Current Reporting StatusYes  
Entity Voluntary FilersNo  
Entity Filer CategorySmaller Reporting Company  
Entity Well-known Seasoned IssuerNo  
Document Period End DateJun. 30, 2017  
Document Fiscal Year Focus2017  
Document Fiscal Period FocusFY  

View differences made from one year to another to evaluate America Great Health's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by America Great Health.

Continue

Assess how America Great Health's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

America Great Health's Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Consolidated Balance Sheets
Consolidated Balance Sheets (parentheticals)
Consolidated Statement Of Shareholders' Equity (deficit)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations
Accounting Policies, By Policy (policies)
Document And Entity Information
Note 1 - Nature Of Business
Note 1 - Nature Of Business (details)
Note 2 - Summary Of Significant Accounting Policies
Note 2 - Summary Of Significant Accounting Policies (details)
Note 3 - Discontinued Operations
Note 3 - Discontinued Operations (details)
Note 3 - Discontinued Operations (details) - Disposal Groups, Including Discontinued Operations
Note 3 - Discontinued Operations (details) - Disposal Groups, Including Discontinued Operations
Note 3 - Discontinued Operations (details) - Disposal Groups, Including Discontinued Operations (parentheticals)
Note 3 - Discontinued Operations (tables)
Note 4 - Related Party Transactions
Note 4 - Related Party Transactions (details)
Note 4 - Related Party Transactions (details) - Schedule Of Related Party Transactions
Note 4 - Related Party Transactions (details) - Schedule Of Related Party Transactions (parentheticals)
Note 4 - Related Party Transactions (tables)
Note 5 - Short-term Loans Payable
Note 5 - Short-term Loans Payable (details)
Note 6 - Convertible, Redeemable Preferred Stock
Note 6 - Convertible, Redeemable Preferred Stock (details)
Note 7 - Shareholders' Deficit
Note 7 - Shareholders' Deficit (details)
Note 8 - Non-controlling Interest
Note 8 - Non-controlling Interest (details)
Note 9 - Income Taxes
Note 9 - Income Taxes (details)
Note 9 - Income Taxes (details) - Schedule Of Deferred Tax Assets And Liabilities
Note 9 - Income Taxes (details) - Schedule Of Effective Income Tax Rate Reconciliation
Note 9 - Income Taxes (tables)
Ticker: AAGH
CIK: 1098009
Form Type: 10-K Annual Report
Accession Number: 0001185185-17-002175
Submitted to the SEC: Fri Oct 13 2017 5:31:19 PM EST
Accepted by the SEC: Fri Oct 13 2017
Period: Friday, June 30, 2017
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/aagh/0001185185-17-002175.htm